Papillomavirus-like particle based vaccines: cervical cancer and beyond

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.1, Iss.4, 2001-07, pp. : 571-581

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cervarix™ – a bivalent L1 virus-like particle vaccine for prevention of human papillomavirus type 16- and 18-associated cervical cancer

By Crosbie Emma J Kitchener Henry C

Expert Opinion on Biological Therapy, Vol. 7, Iss. 3, 2007-03 ,pp. : 391-396

Informa Healthcare

Access to resources Recommend Favorite

Vaccines against cervical cancer

By Jansen Kathrin U

Expert Opinion on Biological Therapy, Vol. 4, Iss. 11, 2004-11 ,pp. : 1803-1809

Informa Healthcare

Access to resources Recommend Favorite

In vitro gene transfer using human papillomavirus‐like particles

By Touze Antoine Coursaget Pierre

Nucleic Acids Research, Vol. 26, Iss. 5, 1998-03 ,pp. : 1317-1324

Oxford University Press

Access to resources Recommend Favorite

Peptide-based vaccines for cancer immunotherapy

By Brinkman Joeli A Fausch Steven C Weber Jeffrey S Kast W Martin

Expert Opinion on Biological Therapy, Vol. 4, Iss. 2, 2004-02 ,pp. : 181-198

Informa Healthcare

Access to resources Recommend Favorite

Dendritic cell-based vaccines and therapies for cancer

By Tatsumi Tomohide Storkus Walter J

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 919-928

Informa Healthcare

Access to resources Recommend Favorite